chrX-108077066-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000217957.10(VSIG1):c.849C>A(p.Asn283Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00001 in 1,095,348 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000217957.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VSIG1 | NM_182607.5 | c.849C>A | p.Asn283Lys | missense_variant | 7/7 | ENST00000217957.10 | NP_872413.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSIG1 | ENST00000217957.10 | c.849C>A | p.Asn283Lys | missense_variant | 7/7 | 1 | NM_182607.5 | ENSP00000217957 | P2 | |
VSIG1 | ENST00000415430.7 | c.957C>A | p.Asn319Lys | missense_variant | 8/8 | 2 | ENSP00000402219 | A2 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.0000279 AC: 5AN: 178937Hom.: 0 AF XY: 0.0000156 AC XY: 1AN XY: 63971
GnomAD4 exome AF: 0.0000100 AC: 11AN: 1095348Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 5AN XY: 361244
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 18, 2023 | The c.957C>A (p.N319K) alteration is located in exon 8 (coding exon 8) of the VSIG1 gene. This alteration results from a C to A substitution at nucleotide position 957, causing the asparagine (N) at amino acid position 319 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at